These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 30146240)

  • 1. A Glycoengineered Enzyme with Multiple Mannose-6-Phosphates Is Internalized into Diseased Cells to Restore Its Activity in Lysosomes.
    Hyun JY; Kim S; Lee HS; Shin I
    Cell Chem Biol; 2018 Oct; 25(10):1255-1267.e8. PubMed ID: 30146240
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Introduction of an N-glycan sequon into HEXA enhances human beta-hexosaminidase cellular uptake in a model of Sandhoff disease.
    Matsuoka K; Tsuji D; Aikawa S; Matsuzawa F; Sakuraba H; Itoh K
    Mol Ther; 2010 Aug; 18(8):1519-26. PubMed ID: 20571546
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular pathologies of and enzyme replacement therapies for lysosomal diseases.
    Sakuraba H; Sawada M; Matsuzawa F; Aikawa S; Chiba Y; Jigami Y; Itoh K
    CNS Neurol Disord Drug Targets; 2006 Aug; 5(4):401-13. PubMed ID: 16918392
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retrovirus-mediated transfer and expression of beta-hexosaminidase alpha-chain cDNA in human fibroblasts from G(M2)-gangliosidosis B1 variant.
    Teixeira CA; Sena-Esteves M; Lopes L; Sá Miranda MC; Ribeiro MG
    Hum Gene Ther; 2001 Sep; 12(14):1771-83. PubMed ID: 11560770
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A shortcut to the lysosome: the mannose-6-phosphate-independent pathway.
    Coutinho MF; Prata MJ; Alves S
    Mol Genet Metab; 2012 Nov; 107(3):257-66. PubMed ID: 22884962
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuronal lysosomal enzyme replacement using fragment C of tetanus toxin.
    Dobrenis K; Joseph A; Rattazzi MC
    Proc Natl Acad Sci U S A; 1992 Mar; 89(6):2297-301. PubMed ID: 1532255
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficient Preparation and Bioactivity Evaluation of Glycan-Defined Glycoproteins.
    Hyun JY; Kim S; Lee CH; Lee HS; Shin I
    ACS Chem Biol; 2021 Oct; 16(10):1930-1940. PubMed ID: 33232137
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of plasma membrane associated mature beta-hexosaminidase A, active towards GM2 ganglioside, in human fibroblasts.
    Mencarelli S; Cavalieri C; Magini A; Tancini B; Basso L; Lemansky P; Hasilik A; Li YT; Chigorno V; Orlacchio A; Emiliani C; Sonnino S
    FEBS Lett; 2005 Oct; 579(25):5501-6. PubMed ID: 16212960
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting macrophages with baculovirus-produced lysosomal enzymes: implications for enzyme replacement therapy of the glycoprotein storage disorder galactosialidosis.
    Bonten EJ; Wang D; Toy JN; Mann L; Mignardot A; Yogalingam G; D'Azzo A
    FASEB J; 2004 Jun; 18(9):971-3. PubMed ID: 15084520
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lysosomal enzyme precursors in human fibroblasts. Activation of cathepsin D precursor in vitro and activity of beta-hexosaminidase A precursor towards ganglioside GM2.
    Hasilik A; von Figura K; Conzelmann E; Nehrkorn H; Sandhoff K
    Eur J Biochem; 1982 Jul; 125(2):317-21. PubMed ID: 6214395
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mice deficient in Neu4 sialidase exhibit abnormal ganglioside catabolism and lysosomal storage.
    Seyrantepe V; Canuel M; Carpentier S; Landry K; Durand S; Liang F; Zeng J; Caqueret A; Gravel RA; Marchesini S; Zwingmann C; Michaud J; Morales CR; Levade T; Pshezhetsky AV
    Hum Mol Genet; 2008 Jun; 17(11):1556-68. PubMed ID: 18270209
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A selective inhibitor Gal-PUGNAc of human lysosomal beta-hexosaminidases modulates levels of the ganglioside GM2 in neuroblastoma cells.
    Stubbs KA; Macauley MS; Vocadlo DJ
    Angew Chem Int Ed Engl; 2009; 48(7):1300-3. PubMed ID: 19130519
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Production of recombinant beta-hexosaminidase A, a potential enzyme for replacement therapy for Tay-Sachs and Sandhoff diseases, in the methylotrophic yeast Ogataea minuta.
    Akeboshi H; Chiba Y; Kasahara Y; Takashiba M; Takaoka Y; Ohsawa M; Tajima Y; Kawashima I; Tsuji D; Itoh K; Sakuraba H; Jigami Y
    Appl Environ Microbiol; 2007 Aug; 73(15):4805-12. PubMed ID: 17557860
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis of a human lysosomal enzyme, beta-hexosaminidase B, using the baculovirus expression system.
    Boose JA; Tifft CJ; Proia RL; Myerowitz R
    Protein Expr Purif; 1990 Nov; 1(2):111-20. PubMed ID: 1967020
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bicistronic lentiviral vector corrects beta-hexosaminidase deficiency in transduced and cross-corrected human Sandhoff fibroblasts.
    Arfi A; Bourgoin C; Basso L; Emiliani C; Tancini B; Chigorno V; Li YT; Orlacchio A; Poenaru L; Sonnino S; Caillaud C
    Neurobiol Dis; 2005 Nov; 20(2):583-93. PubMed ID: 15953731
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glyco-engineering strategies for the development of therapeutic enzymes with improved efficacy for the treatment of lysosomal storage diseases.
    Oh DB
    BMB Rep; 2015 Aug; 48(8):438-44. PubMed ID: 25999178
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative study on mannose 6-phosphate residue contents of recombinant lysosomal enzymes.
    Togawa T; Takada M; Aizawa Y; Tsukimura T; Chiba Y; Sakuraba H
    Mol Genet Metab; 2014 Mar; 111(3):369-373. PubMed ID: 24439675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Two mechanisms for the recapture of extracellular GM2 activator protein: evidence for a major secretory form of the protein.
    Rigat B; Wang W; Leung A; Mahuran DJ
    Biochemistry; 1997 Jul; 36(27):8325-31. PubMed ID: 9204879
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A bacterial glycosidase enables mannose-6-phosphate modification and improved cellular uptake of yeast-produced recombinant human lysosomal enzymes.
    Tiels P; Baranova E; Piens K; De Visscher C; Pynaert G; Nerinckx W; Stout J; Fudalej F; Hulpiau P; Tännler S; Geysens S; Van Hecke A; Valevska A; Vervecken W; Remaut H; Callewaert N
    Nat Biotechnol; 2012 Dec; 30(12):1225-31. PubMed ID: 23159880
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevention of lysosomal storage in Tay-Sachs mice treated with N-butyldeoxynojirimycin.
    Platt FM; Neises GR; Reinkensmeier G; Townsend MJ; Perry VH; Proia RL; Winchester B; Dwek RA; Butters TD
    Science; 1997 Apr; 276(5311):428-31. PubMed ID: 9103204
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.